Nisa Investment Advisors LLC Sells 12,823 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 88.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,703 shares of the company’s stock after selling 12,823 shares during the period. Nisa Investment Advisors LLC’s holdings in Option Care Health were worth $40,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Sheets Smith Wealth Management boosted its holdings in Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after acquiring an additional 550 shares during the period. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of Option Care Health by 6.2% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 943,300 shares of the company’s stock valued at $21,885,000 after purchasing an additional 54,830 shares during the period. UMB Bank n.a. grew its holdings in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Diversify Wealth Management LLC increased its stake in shares of Option Care Health by 31.7% in the fourth quarter. Diversify Wealth Management LLC now owns 13,560 shares of the company’s stock worth $325,000 after buying an additional 3,261 shares during the period. Finally, Wedge Capital Management L L P NC bought a new stake in Option Care Health during the 4th quarter valued at $3,245,000. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Trading Down 1.5 %

NASDAQ OPCH opened at $30.92 on Friday. The stock’s 50 day moving average is $25.16 and its 200 day moving average is $27.91. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $5.26 billion, a PE ratio of 25.98, a P/E/G ratio of 2.20 and a beta of 1.31. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Barrington Research upped their target price on Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.